Published in Technology (Singap World Sci) on March 01, 2015
Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol Bioeng (2015) 0.83
Screening applications in drug discovery based on microfluidic technology. Biomicrofluidics (2016) 0.81
Biotunable acoustic node assembly of organoids. Adv Healthc Mater (2015) 0.79
A Microfabricated Platform for Generating Physiologically-Relevant Hepatocyte Zonation. Sci Rep (2016) 0.75
Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology. Technology (Singap World Sci) (2017) 0.75
Generation and manipulation of hydrogel microcapsules by droplet-based microfluidics for mammalian cell culture. Lab Chip (2017) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
A general model for the origin of allometric scaling laws in biology. Science (1997) 24.91
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov (2004) 15.57
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). Anal Chem (1998) 15.53
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol (1969) 6.74
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics (2004) 5.12
A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J Cell Biol (1968) 4.95
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) (2006) 4.84
Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science (2003) 4.56
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A (1997) 4.33
Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J (1999) 4.22
Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol (1977) 4.13
Mechanisms of hepatotoxicity. Toxicol Sci (2002) 4.13
The liver as a lymphoid organ. Annu Rev Immunol (2009) 4.03
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
A passive pumping method for microfluidic devices. Lab Chip (2002) 3.87
Cellular heterogeneity: do differences make a difference? Cell (2010) 3.57
Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A (2007) 3.53
Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov (2005) 3.23
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog (1991) 3.21
Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol (1996) 3.13
Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng (2003) 3.04
Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J (1989) 2.89
PDMS absorption of small molecules and consequences in microfluidic applications. Lab Chip (2006) 2.86
Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Anal Chem (2000) 2.81
Droplet microfluidics for high-throughput biological assays. Lab Chip (2012) 2.72
The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology (1985) 2.60
Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci (2008) 2.60
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol (2006) 2.59
Role of Kupffer cells in host defense and liver disease. Liver Int (2006) 2.55
Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A (1992) 2.54
High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem (2008) 2.48
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov (2007) 2.32
Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int Rev Cytol (1980) 2.32
Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol (2009) 2.26
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol (2008) 2.23
Multiple functionalities of polyelectrolyte multilayer films: new biomedical applications. Adv Mater (2010) 2.22
Toxicity testing in the 21st century: a vision and a strategy. Reprod Toxicol (2007) 2.21
Allometric scaling of mammalian metabolism. J Exp Biol (2005) 2.20
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther (2010) 2.13
Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology (2000) 2.12
Spending on new drug development1. Health Econ (2010) 2.09
Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr (1996) 2.03
A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip (2007) 2.03
Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts. J Biomed Mater Res (1997) 2.00
A high-throughput microfluidic real-time gene expression living cell array. Lab Chip (2006) 1.93
Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J (1999) 1.90
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
The chemistrode: a droplet-based microfluidic device for stimulation and recording with high temporal, spatial, and chemical resolution. Proc Natl Acad Sci U S A (2008) 1.90
Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol (1985) 1.90
Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J (1996) 1.90
Perfused multiwell plate for 3D liver tissue engineering. Lab Chip (2009) 1.88
Functional hepatocellular heterogeneity. Hepatology (1982) 1.88
A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng (2002) 1.87
Integration of cell culture and microfabrication technology. Biotechnol Prog (2003) 1.86
Sizing up allometric scaling theory. PLoS Comput Biol (2008) 1.84
Solvent-resistant photocurable liquid fluoropolymers for microfluidic device fabrication [corrected]. J Am Chem Soc (2004) 1.78
Engineers are from PDMS-land, Biologists are from Polystyrenia. Lab Chip (2012) 1.77
An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng (2007) 1.75
Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci (2006) 1.75
Microfabrication of hepatocyte/fibroblast co-cultures: role of homotypic cell interactions. Biotechnol Prog (1998) 1.74
Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov (2010) 1.73
Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol (2007) 1.70
High-resolution dose-response screening using droplet-based microfluidics. Proc Natl Acad Sci U S A (2011) 1.69
Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp Cell Res (1983) 1.68
Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol (2011) 1.65
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis (2001) 1.62
The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am J Physiol Gastrointest Liver Physiol (2007) 1.61
A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab (2005) 1.61
A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip (2010) 1.60
Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology (1988) 1.59
Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng (2003) 1.58
Development of a hybrid bioartificial liver. Ann Surg (1993) 1.57
Are animal models predictive for humans? Philos Ethics Humanit Med (2009) 1.57
When PDMS isn't the best. What are its weaknesses, and which other polymers can researchers add to their toolboxes? Anal Chem (2007) 1.55
Why drugs fail--a study on side effects in new chemical entities. Curr Pharm Des (2005) 1.54
Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab Chip (2004) 1.53
Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol (1992) 1.53
Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal Chem (2006) 1.53
Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? Hepatology (2004) 1.51
A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip (2009) 1.51
Dynamic gene expression profiling using a microfabricated living cell array. Anal Chem (2004) 1.50
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50
Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci (2008) 1.49
A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip (2009) 1.49
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology (2008) 1.47
Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol (1994) 1.46
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Characterization and resolution of evaporation-mediated osmolality shifts that constrain microfluidic cell culture in poly(dimethylsiloxane) devices. Anal Chem (2007) 1.45
"Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A. Am J Anat (1971) 1.45